Our recent studies demonstrate that X-linked inhibitor of apoptosis protein (XIAP) is essential for regulating colorectal cancer invasion. Here, we discovered that RhoGDIb was a key XIAP downstream effector mediating bladder cancer (BC) invasion in vitro and in vivo. We found that both XIAP and RhoGDIb expressions were consistently elevated in BCs of N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-treated mice in comparison to bladder tissues from vehicle-treated mice and human BCs in comparison to the paired adjacent normal bladder tissues. Knockdown of XIAP attenuated RhoGDIb expression and reduced cancer cell invasion, whereas RhoGDIb expression was attenuated in BBN-treated urothelium of RING-deletion knockin mice. Mechanistically, XIAP stabilized RhoGDIb mRNA by its positively regulating nucleolin mRNA stability via Erks-dependent manner. Moreover, ectopic expression of GFP-RhoGDIb in T24T(shXIAP) cells restored its lung metastasis in nude mice. Our results demonstrate that XIAP-regulated Erks/nucleolin/RhoGDIb axis promoted BC invasion and lung metastasis.
Introduction
Bladder cancer (BC) is the disease with malignant growth of urinary, 1 and about 74,000 new cases were diagnosed and 16,000 deaths were associated with bladder cancers, according to the report from the National Cancer Institute in 2015. 2 The majority of human bladder cancer is transitional cell carcinomas derived from the urothelium, which accounts for >90% of bladder carcinomas. 3 The depth of invasion of the bladder wall is closely associated clinic treatment of bladder cancers. 4 Since high-grade muscle-invasive bladder cancer (HGIBC) can progress to life threatening metastases, invasive malignant tumors contribute to nearly 100% of bladder cancer-related deaths. In light of this information, it is imperative to elucidate the mechanisms underlying bladder cancer invasion and metastasis to mitigate the mortality of highly invasive human bladder cancer.
X-linked inhibitor of apoptosis protein (XIAP) is a member of inhibitor of apoptosis protein (IAP) family with structure characterized by three baculoviral IAP repeat (BIR) domains and an ubiquitin associated (UBA) Ring domain. 5 In addition to numerous studies elucidating the mechanisms of anti-apoptotic function of XIAP, our recent studies have revealed several non-apoptosis-related functions of XIAP and its RING domain, such as upregulation of Cyclin D1 with promoting bladder cancer cell growth 6 and promotion of colon cancer cell invasion via inhibiting RhoGDIa SUMOylation at lys-138. 7 XIAP function as a metastatic driver can also be substituted by its activation of the NFjB via the E3 ligase activity in human prostate cancer cells. 8 In contrast, several other reports depicted XIAP as a tumor suppressor due to its capable of suppressing cell migration. Notable examples include a study depicting that Caveolin-1-mediated XIAP recruiting to the a-integrin complex can enhance cell adhesion. 9 Another study describes how XIAP-mediated ubiquitination regulates C-RAF kinase, which, as the effector protein of Ras, initiates MAPK cascades and thereby mediating cell growth and migration. 10 Nevertheless, the overall role of XIAP in cancer progression might be dependent on cancer tissues and cell types. Our most recent studies reveal that XIAP and its RING domain was crucial for human BC invasion in vitro cell culture model and invasive bladder cancer development in mice exposed to Nbutyl-N-(4-hydroxybutyl) nitrosamine (BBN) in drinking water in vivo animal model. 11 Thus, the discovery of XIAP downstream effectors and evaluation of the mechanisms underlying XIAP and its RING domain modulation of human BC invasion and metastasis is of tremendous importance for understanding nature of the BC invasion and metastasis.
The RhoGDI family is consists of three members, including RhoGDIa, RhoGDIb and RhoGDIg, which modulate small GTPase activity via regulating GDP/GTP exchange. 12 RhoGDIa is expressed ubiquitously in cells and tissues, 12 whereas
RhoGDIb commonly exists in hematopoietic, endothelial and urothelial cells. 13 Particularly, the latter has been reported in bladder cancer and other cancer types. 14 RhoGDIb has been thought to act as a suppressor for both migration and metastasis in bladder, ovarian, breast and lung cancers. 15 And phosphorylation of RhoGDIb induced by Src has been reported to enhance its function as suppressor for metastasis in UMUC3 cells. 16 RhoGDIb expression level is also thought to predict prognosis of BC patients. 13 However, other reports have shown that
RhoGDIb promotes tumor growth and malignant progression in gastric cancer, 17 while overexpression of RhoGDIb enhances gastric cancer cell invasion and metastasis. 18 During our investigation of the contribution of XIAP overexpression to human BC invasion and metastasis, we unexpectedly found that both RhoGDIb and XIAP were consistently elevated in most of human bladder cancer tissues and in all BBN-induced high invasive BCs. Further studies discovered that XIAP was crucial for maintaining RhoGDIb mRNA stability and thereby increasing its protein expression and facilitating human bladder cancer cell invasion and metastasis both in vitro and in vivo.
Material and Methods

Plasmids, antibodies and reagents
Short hairpin RNA (shRNA) specific targeting XIAP, RhoGDIb or nucleolin, were purchased from Open . DN-Erk1 and HA-XIAP plasmids were described in our previous publications. 7, 21 Antibodies against RhoGDIa, RhoGDIb, HuR and the control IgG were bought from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies against GFP, nucleolin and b-Actin were bought from Sigma (St. Louis, MO). Antibodies specific for XIAP, VHL, Erk, p-Erk and GAPDH were purchased from Cell Signaling Technology, Inc. (Danvers, MA), whereas HA antibody was purchased from Covance, Inc. (Princeton, NJ). Cycloheximide (CHX) was bought from Calbionchem (San Diego, CA). The dual luciferase assay substrate was purchased from Promega (Madison, WI).
Cells and transfectants
The human bladder cancer cell lines, TccSup and T24T, and colon cancer cell HCT116 were cultured and used as described in our previous studies. 22, 23 All cell lines, including T24T, TccSup, HCT116, were authenticated every 6-12 months by testing STR loci and gender by using PowerPlexV R 16 HS System by Genetica DNA Laboratories (Burlington, NC) or Microread Genetics Co., Ltd (Beijing, China), and the results were 100%, 100% and 94% matched with the data in the ATCC STR DATABASE, respectively. Transfections of shRNA specific targeting human XIAP, RhoGDIb or Erk1/2 into TccSup or T24T cells were conducted by using PolyJet TM transfection reagent (SignaGen Laboratories, Rockville, MD) according to the manufacturer's protocol, followed up by stable transfectant selection with hygromycin (Cellgro, Manassas, VA). Transfections of GFP-RhoGDIb or shRNA specific targeting human nucleolin into T24T, TccSup and T24T(shXIAP) cells, were conducted by using the aforementioned reagent, except with puromycin (Cellgro, Manassas,
What's new?
Depth of tumor invasion in the bladder wall is closely associated with metastasis in bladder cancer. The factors driving invasion and metastasis in the bladder, however, are not fully known. Here, both X-linked inhibitor of apoptosis protein (XIAP) and RhoGDIb, a modulator of small GTPase activity, were found to be overexpressed in high-grade invasive human bladder cancer specimens. Moreover, in cells, XIAP positively regulated RhoGDIb expression and invasion, while in mice with bladder cancer, RhoGDIb expression served a critical role in lung metastasis. Further study of these novel players could help improve preventative and therapeutic strategies for bladder cancer.
VA) being the selective agent. GFP-nucleolin was transiently transfected into 293 T cells using PolyJet TM transfection reagent. All cell cultures and transfectants were maintained at 378C 5% CO 2 using the corresponding mediums supplemented with 1% penicillin/streptomycin, and 2 mM L-glutamine (Life Technologies, Grand Island, NY).
Bladder cancer tissue specimens 
Animal experiments and bladder tissue
The C57BL/6 mice at age of 6-8 weeks with XIAP-WT or XIAP-DRING, which were generated and described in previous report, 24 were randomly divided into four groups as indicated: XIAP-WT mice normal control, XIAP-WT mice treated with 0.5% BBN in water, XIAP-DRING mice normal control, XIAP-DRING mice treated with 0.5% BBN in water, after 6 months, the mice were then sacrificed to evaluate the expression of RhoGDIb and Nucleolin and/or bladder pathologic analysis.
Immunohistochemistry paraffin of mouse lung specimens
Bladder tissues obtained from the sacrificed mice were formalin-fixed and paraffin-embedded. 
Luciferase reporter assay
Human RhoGDIb promoter-driven luciferase reporter or nucleolin promoter-driven luciferase reporter was transiently co-transfected together with pRL-TK into various TccSup and T24T transfectants, respectively. Twenty-four hours after transfection, cells were lysed for luciferase activity assay and internal TK assay by using the Dual-Luciferase Reporter Assay System following manufacturer's protocol (Promega, Madison, WI).
RNA-IP assay
293 T cells were cultured in 10-cm dishes until reaching 70-80% confluent, and the cells were then transiently transfected with GFP-nucleolin. After a 24 hr post-transfection, cells were harvested after twice washing with PBS and the RNA was extracted as previously described. 22 Then the RNA was subjected to reverse transcription polymerase chain reaction (RT-PCR) as described below.
Reverse transcription-polymerase chain reaction (RT-PCR) and quantitative RT-PCR
Cells were collected in 1 ml of TRIzol reagent (Invitrogen, Carlsbad, CA) and total RNA was extracted according to manufacturer's instruction. RNAs were reverse transcripted and PCR was performed in our previous report. 22 Specific primers of human RhoGDIb (forward: 5 0 -acc cgg ctc acc ctg gtt tgt-3 0 , reverse: 5 0 -aca cca gtc ctg tag gtg tgc tg-3 0 ), human nucleolin (forward: 5 0 -acc taa tgc cag aag cca gcc a-3 0 , reverse: 5 0 -ttg ccc gaa cgg agc cgt c-3 0 ), mouse nucleolin (forword: 5 0 -gag gac ccc ctt cgt cgc ct-3 0 and reverse: 5 0 -gcc tca ccg tgg gtt ttg cca-3 0 ) and human GAPDH (forward: 5 0 -gat gat ctt gag gct gtt gtc, reverse: 5 0 -cag ggc tgc ttt taa ctc tg-3 0 ) were used for PCR amplification.
ATP cell viability assay
Cells were seeded into 96-well plates at a density of 10,000 cells per well and allowed to adhere overnight. The cell culture medium was then replaced with 0.1% FBS DMEM and cultured for 12 hr. The cells were extracted with 50 ll of lysis buffer at the various time points. Cell viability was evaluated by utilizing the CellTiter-Glo Luminescent Cell Viability Assay Kit (Promega, Madison, WI) as described in previous report. 25 The results were expressed as relative proliferation rate, which was calculated as following: relative proliferation rate 5ATP activity on the nth day/ATP activity on 0 day.
Western blot
Whole cell extracts or bladder tissue extracts were collected with lysis buffer (10 mM Tris-HCl, pH 7.4, 1%SDS, 1 mM Na 3 VO 4 and proteasome inhibitor followed by sonication to fracture nucleic acids). Protein extracts were quantified using Nano Drop 2000 (Thermo Scientific, Waltham, MA), and then subjected to Western blot as described in our previous studies. 22 Wound healing assay T24T, TccSup and their various transfectants were seeded into six-well plates. When cell confluence reached 80-90%, wounds were created by using sterile pipette tips, and images were taken and evaluated as previous described. 22 
Cell invasion assay
The control (uncoated) and matrigel inserts of BD BiocoatTM (BD Biosciences, Bedford, MA) were used for cell invasion assay. BC cell suspension (0.5 ml of 2.5 3 10 4 cells/ ml) was added to each insert. After incubation in a humidified incubator at 378C, 5% CO 2 atmosphere for 24 hr, nonmigrating or non-invading cells were wiped using cotton swab according to manufacturer's instructions. Cell numbers were quantified and the images were captured under inverted microscope (Olympas, Center Valley, PA) as describe in our previous study.
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T24T cell lung metastatic assay
All animal studies were performed in the animal institute of Wenzhou Medical University according to the protocols approved by the Medical Experimental Animal Care Commission of Wenzhou Medical University. Female athymic (nu1/nu1) mice were purchased from Shanghai Silaike Experimental Animal Company, Ltd. (License No. SCXK, Shanghai 2010 0002; Shanghai, China). Seventy-two mice at age of 5-6 weeks were randomly divided into each group, and transfectants of T24T(Nonsense), T24T(shRhoGDIb), T24T(pEGFP), T24T(GFP-RhoGDIb), T24T(shXIAP/ pEGFP), T24T(shXIAP/GFP-RhoGDIb), was injected into nude mice via an I.V. lateral tail vein injection (1.5-2.5 3 10 6 cells in 100 ml PBS/mouse), respectively. The mice will be evaluated and weighted twice a week. The lungs were removed by dissection after natural death or being euthanized at indicated times after injection. Six or eight lungs from indicated group were fixed in Bouin's fixative solution (Sigma, St. Louis, MO) for 24 hr and the numbers of lung surface metastatic lesions were counted on each lobe of every specimen. The left lungs in each group were fixed and embedded in paraffin for histopathological evaluation.
Statistical analysis
Ordinary one-way ANOVA software was used to statistically determine the significance difference among each of experimental groups. If a significant difference was obtained by ANOVA, the Tukey-Kramer multiple-comparisons t-test was also used to verify the significance of the difference. Immunohistochemistry results were analyzed by Kolmogorov-Smirnov test and Spearman correlation test. The data were presented as Mean 6 SD, and the differences were considered to be significant when p 0.05.
Results
The co-related overexpression of RhoGDIb and XIAP in both human bladder cancers and BBN-induced mouse bladder cancers
RhoGDIb mRNA levels are reported to be downregulated in human BC patients by using the HU-133 A Affymetrix array, whereas the results depicting from the Cancer Genome Atlas shows the prominent amplifications of RhoGDIb in human BCs (TCGA, http://www.cbioportal.org/public-portal/). Since protein is the major functional carrier of the gene, we first used Western blot to evaluate RhoGDIb protein expression in human bladder carcinomas in comparison to their paired adjacent normal bladder tissues. The results unanticipatedly showed that RhoGDIb protein expression was remarkably elevated in 11 of 12 (91.7%) of human BC patients (Fig. 1a) , demonstrating that RhoGDIb protein is overexpressed in most of human BC patients. Since XIAP mRNA is also upregulated in human BC tissues 27 and XIAP is crucial for colorectal cancer cell migration and invasion through its inhibition of RhoGDIa SUMOylation at L138, 7, 28 we would assess the XIAP abundance in same BC patients for observation of RhoGDIb protein expression. As shown in Figure 1a , among 11 patients with RhoGDIb overexpression, eight of them (72.7%) with XIAP remarkably elevated in comparison to their paired normal bladder tissues (Fig. 1a) . The results obtained from immunohistochemical (IHC) staining also showed that expression of RhoGDIb and XIAPs was consistently elevated in BC tissues in comparison to the paired adjacent normal bladder tissues (Figs. 1b-1e, p < 0.01, N 5 32). The statistic correlation analysis revealed that RhoGDIb protein expression was highly corelated to XIAP expression (Fig. 1f , r 5 0.754, p < 0.01). Chemical carcinogen N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) is able to target mouse urothelium, and induces a wide range of BC phenotypes, including hyperplasia, dysplasia, carcinoma in situ and muscle-invasive bladder cancer. Histopathological analysis reveals that mouse BC induced by BBN mimics the progression of human bladder from non-invasive carcinoma to muscle-invasive carcinoma. To evaluate the status of RhoGDIb in BBN-induced mouse BCs, HE staining was shown in Figure 1g , and IHC was used to determine RhoGDIb abundances in BBN-induced mouse BCs. XIAP-mediated nucleolin expression and consequent stabilized mRNA of RhoGDIb RNA binding proteins (RBPs), such as human antigen R (HuR), Von Hippel-Lindau (VHL) and nucleolin, serve pivotal role with regarding to regulating mRNA stability.
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Given above results showing that XIAP regulates RhoGDIb mRNA stability, the expression levels of these potential targets were analyzed in XIAP knockdown and nonsense transfectants. Western blot analysis showed that nucleolin expression was profoundly decreased in T24T (Fig. 3a) and TccSup ( Fig. S2a ) XIAP knockdown transfectants, while HuR and VHL expression only showed minimal alteration between the paired transfectants ( Fig. 3a and Fig. S2a) . Consistently, the similar results were observed in XIAP2/2(Vector) cells in comparison to its parental HCT116-WT cells, while reconstitutional expression of HA-XIAP in XIAP2/2 cells, XIAP2/2(HA-XIAP), restored nucleolin expression (Fig.  3b) . It was important to note that the nucleolin protein was Figure 1 . RhoGDIb was overexpressed in BC of human patients and BBN-induced mice. (a) Total protein lysates were prepared from the cancerous (T) and their paired adjacent normal (N) tissues of human BC patients were collected as described in "Material and Methods," the total proteins were extracted and then subjected to Western blotting analyses, and specific antibodies against XIAP and RhoGDIb were used to determine the level of XIAP and RhoGDIb proteins. (b-f) RhoGDIb and XIAPs level was evaluated by using IHC staining in bladder cancer tissues in comparison to the paired normal bladder tissues (n 5 32). IHC images were captured under microscopy. (b and d) , and the quantitative (c and e) and correlation of XIAP expression with RhoGDIb level was analyzed and presented (f). (g-i) Upon 23 weeks treatment of mice with or without BBN, the bladder tissues from indicated mice were pathologically analyzed by H&E staining (g) and by IHC staining to evaluate RhoGDIb expression (h). Homotypic IgG was used as negative control (h) and the optical density was calculated as described in "Material and Methods" (i). The results were presented as mean 6 SD from at least triplicate experiments and asterisk (*) indicated a significant difference (p < 0.05).
remarkably overexpressed in BBN-induced mouse high invasive bladder cancers (Figs. 3c and 3d) . Consistent with RhoGDIb downregulation in BBN-treated mouse bladder epithelium in XIAP-DRING knockin mice, nucleolin abundance was also attenuated in XIAP-DRING knockin mice following BBN exposure (Figs. 3e and 3f) , revealing that XIAP and its RING domain play an important role in nucleolin expression in bladder epithelium both in vitro and in vivo.
RBPs could directly bind to their target mRNA, by which increases its stability. 32 Thus, to determine whether nucleolin can bind to RhoGDIb mRNA, GFP-nucleolin was transiently transfected into 293 T cells followed by RNA-IP. RT-PCR analysis showed that RhoGDIb mRNA could be pulled down by nucleolin antibody (Fig. 3g) , indicating that nucleolin did bind to RhoGDIb mRNA. To test whether this binding activity enhanced RhoGDIb mRNA stability and subsequently increased its protein expression, shRNA specific targeting nucleolin was stably transfected into T24T and mouse embryonic fibroblast (MEF) cells, respectively. The results showed that compared to nonsense transfectants, nucleolin knockdown attenuated RhoGDIb protein expression in both T24T and MEF cells (Fig. 3h) . In addition, RhoGDIb mRNA level in T24T(shNCL) transfectants (Fig. 3i) and MEF(shNCL) (Fig. 3j) was markedly reduced as compared to their corresponding nonsense transfectants, suggesting that nucleolin is not only able to bind to RhoGDIb mRNA, but also is pivotal for RhoGDIb mRNA and protein expression.
Erks activation was crucial for XIAP upregulation of nucleolin mRNA stability
Above results indicate that nucleolin protein expression is downregulated in XIAP knockdown BC cell lines and in mouse urothelium of XIAP-DRING knockin mice. To elucidate the molecular mechanism underlying XIAP regulation of nucleolin protein, the nucleolin mRNA expression levels were evaluated in XIAP knockdown transfectants using real-time PCR assay. As shown in the left panel of Figure 4a and Figure S3a, knockdown of XIAP resulted in a reduction of nucleolin mRNA levels in both T24T and TccSup cells. The results from subsequent testing in HCT116 cells also showed that nucleolin mRNA level was diminished in XIAP-deficient cells as compared to that in HCT116-WT or XIAP2/2(HA-XIAP) (Fig. 4b) . A nucleolin promoter-driven luciferase reporter was then used to determine whether transcription or post-transcription regulation resulted in this mRNA alteration. The results revealed that the relative nucleolin promoter transcriptional activity in either T24T(shXIAP) (Fig.  4a, right panel) or TccSup(shXIAP) (Fig. S3a, right panel) cells was significantly increased in comparison to their corresponding scramble transfectants, excluding possibility of XIAP upregulating nucleolin transcription and further suggesting that XIAP might regulate nucleolin mRNA stability.
To test this notion, the cells were treated by 5 lM Act D for 2 hr or 4 hr, and total RNA was then extracted and subjected to real-time PCR for evaluation of nucleolin mRNA levels. Treatment of T24T(shXIAP) and TccSup (shXIAP) transfectants with Act D for 4 hr, there was only about 40% and 20% nucleolin mRNA remaining, which was significantly decreased in comparison to nonsense cells (about 60% nucleolin mRNA remaining) under the same experimental conditions ( Fig. 4c and Fig. S3b ), respectively. Our results reveal that XIAP promotes nucleolin expression through lengthening the half-life of nucleolin mRNA. Given that XIAP does not directly bind to nucleolin mRNA, we anticipate that XIAP utilizes an intermediary mechanism that can regulate nucleolin mRNA stability. The extracellular-regulated protein kinases (Erks) has been reported to be capable of lengthening the half-life of nucleolin mRNA. 33 We therefore, next determine the potential effect of XIAP in regulation of Erks activation. As shown in left panel of Figure 4d and Figure S3c , Erks phosphorylation in T24T(shXIAP) or TccSup(shXIAP) cells was markedly suppressed in comparison to their scramble control transfectants, T24T(Nonsense) or TccSup(Nonsense). The results from XIAP-deficient HCT116 cells also indicated that Erks phosphorylation was inhibited in XIAP2/2 cells in comparison to either HCT116(Vector) cells, or HA-XIAP reconstitutive expressed XIAP2/2 cells, XIAP2/2(HA-XIAP) cells (Fig. 4d, right panel) . To determine role of Erks in regulation of nucleolin abundance, HA-tagged dominant negative Erk1 (DN-Erk1) or shErk1/2 plasmids were transfected into T24T cell, respectively. And the stable transfectants were used to analyze the expression of nucleolin. The results showed that nucleolin protein (Figs. 4e and 4f) and mRNA (Fig. 4e , low panel) were remarkably suppressed with attenuation of RhoGDIb expression upon DN-Erk1 or shErk1/2 transfection. Subsequently, nucleolin mRNA stability was also decreased in T24T(DN-Erk1) cells as compared to that observed in T24T(Vector) cells (Fig. 4g) . Consistently, inhibition of Erks in T24T cells led to an increase in cell migration and a decrease in BC invasion (Fig. 4h) . Taken together, our results demonstrate that XIAP mediates Erks activation, which in turn stabilizes nucleolin mRNA and increases its abundance, consequently leading to RhoGDIb mRNA stabilization and protein expression, as well as promoting invasion in human BC cells. Erk-dependent regulatory effect of XIAP on nucleolin was also supported by the results showing that overexpression of HA-XIAP was not able to recuse the nucleolin level in T24T(DN-ERk1) transfectants (Fig. S3d) .
XIAP-mediated RhoGDIb was crucial for T24T cell invasion in vitro
To define the effect of RhoGDIb in BC cell migration and invasion, pEGFP-RhoGDIb and its scramble vector pEGFP were transfected into T24T and TccSup cells, respectively. The results obtained from Western blot indicated that GFP- RhoGDIb was successfully transfected and ectopically expressed in both T24T (Fig. 5a) and TccSup (Fig. S4a) cells. A follow-up trans-well assay showed that both T24T and TccSup cells overexpressing GFP-RhoGDIb, T24T(pEGFPRhoGDIb) and TccSup(pEGFP-RhoGDIb), had a remarkably promotive effect on cell invasion although cell migration capacity was significantly decreased as compared to those in the corresponding scramble vector transfectants (Fig. 5b and Fig. S4b ), suggesting that RhoGDIb promotes BC cell invasion. Moreover, we used shRNA specific targeting human RhoGDIb to stably knock down RhoGDIb expression in T24T cells (Fig. 5c) , and inhibiting RhoGDIb protein expression also had no obvious effect on regulating T24T cell proliferation (Fig. 5d) . Then its effect on T24T cell invasion was evaluated. As shown in Figure 5e , knockdown of RhoGDIb profoundly inhibited invasion ability of T24T cells. To specific define whether RhoGDIb is XIAP downstream effector for its mediation of XIAP regulation of BC invasion, we constitutively expressed RhoGDIb in T24T(shXIAP) cells (Fig. 5f) . The results indicated that ectopic expression of RhoGDIb significantly reversed the inhibition of T24T cell invasion due to specific knockdown of XIAP (Fig. 5g) . Our results clearly demonstrate that RhoGDIb is a key XIAP downstream effector for mediating the invasion of high-grade BCs.
RhoGDIb expression was critical for T24T lung metastasis in vivo nude mice
To evaluate the contribution of RhoGDIb to mediation of BC lung metastasis, T24T(GFP-vector) and T24T(GFPRhoGDIb) stable transfectants were injected into nude mice The cell extracts were subjected to Western blotting using specific antibodies as indicated and total RNA from the transfectants was used to determine nucleolin mRNA levels by using RT-PCR assay. (g) T24T transfectants as indicated were seeded into six-well plate and cultured till 75-80% confluence. The cells were than treated with 5 lM of Act D for indicated time periods. Realtime PCR assay was employed to analyze the stability of nucleolin mRNA. (h) Cell migration (left panel) and invasion (right panel) of transfectants was evaluated and quantitated by using transwell assay. All the results were presented as mean 6 SD from three-independent experiments and the asterisks (*), ( | ) indicated a significant difference (p < 0.05).
via an I.V. lateral tail vein and the lung metastatic abilities of two transfectants were evaluated. The results showed that ectopic expression of RhoGDIb in T24T cells, T24T(GFPRhoGDIb), exhibited a reduction of mouse survival rate in comparison to the nude mice injected with T24T(GFP-vector) cells (Table S2) . Consistent with mouse survival rate, the number and size of lung metastatic tumors in mice injected with T24T(GFP-RhoGDIb) cells was remarkably increased (Table S2 ; Figs. 6a and 6b) . Those results clear indicate that RhoGDIb might be a positive regulator for BC lung metastasis although it inhibited cell migration in same human BC cells. Moreover, knockdown of RhoGDIb in T24T cells, T24T(shRhoGDIb), attenuated its in vivo lung metastatic ability with significantly prolonger of nude mouse survival (Table S3; Figs. 6c and 6d), revealing that RhoGDIb is crucial for T24T cell lung metastasis. To test whether restoration of RhoGDIb expression in T24T(shXIAP) cells could rescue their lung metastatic ability due to XIAP knockdown, T24T(shXIAP/GFP-RhoGDIb) and its scramble transfectant T24T(shXIAP/GFP) was injected into nude mice via an I.V. lateral tail vein and the lung metastatic abilities of two transfectants were evaluated. As shown in Table S4 and Figures 6e and 6f, compared to the mice injected with T24T(shXIAP/ GFP), the survival rate of nude mice injected with T24T(shXIAP/GFP-RhoGDIb) was decreased and the number of lung metastatic tumor was remarkably increased. Moreover, the results obtained from IHC staining for expression level of Ki-67, a well-known cell proliferative marker, revealed that Ki-67 expression was remarkably elevated by ectopic expression of RhoGDIb (Fig. 6g) , and knockdown of RhoGDIb red to a markedly reduction of Ki-67 expression (Fig. 6h) . It is noted that XIAP knockout promotes cancer cell motility through regulating b-actin polymerization in RhoGDIa SUMOylation-dependent manner in human colon HCT116 cells, 28 whereas XIAP knockout inhibited RhoGDIb expression and human-invasive bladder cancer cell invasion with promotion of cancer cell migration. While detailed mechanisms underlying the differences are still under exploring in our group, we anticipate that the biological functional differences might be associated with the expression ratio of RhoGDIb/RhoGDIa between human colon cancer and bladder cancer cells. As shown in Figure S5 , RhoGDIb was highly expressed in both human bladder cancer cell lines (T24T and TccSup), whereas it was barely detectable in human colon HCT116 cells. In contrast, RhoGDIa expression in HCT116 cells was remarkably higher than that in T24T and TccSup cells (Fig. S5) . Thus, we anticipate that XIAP mainly interacts with RhoGDIa and regulates its SUMOylation, as well as its function in regulation of cell motility in human colon cancer cells, while in bladder cancer cells, XIAP mainly targets RhoGDIb expression and its function in cancer cell invasion.
Collectively, our results demonstrate that the forced expression of RhoGDIb in T24T(shXIAP) cells can reverse the inhibition of T24T cell lung metastasis in nude mice due to XIAP knockdown, further revealing that RhoGDIb is a key XIAP downstream effector being responsible for its mediating BC lung metastatic ability.
Discussion
The function of XIAP in regulating cancer cell motility varies upon cancer types. [7] [8] [9] Although our most recent studies indicate that BCs of human patients and BBN-exposed mice exhibit overexpression of XIAP, which mediates human BC cell invasion in vitro and invasive BC development in vivo, nothing is known about XIAP-regulated downstream effector(s) that mediates BC invasion and metastasis. In current studies, we un-anticipatively found that XIAP and RhoGDIb protein abundances were consistently elevated in most of cases of (72.7%) human BCs and all (100%) of BBN-induced mouse high invasive BCs, which is distinct from previous report that RhoGDIb is downregulated in human BCs. 13 The results obtained from IHC staining showed that XIAP overexpression was highly related to RhoGDIb expression in human BCs. The investigation from lost-expression studies indicated that XIAP/its RING domain were crucial for maintaining RhoGDIb protein levels in human BC cell lines and in mouse BC tissues. We also discovered that RhoGDIb was a key XIAP downstream effector that mediated invasion in vitro cultured human BC cells and BC cell lung metastasis in vivo nude mice injected with T24T cells. Mechanistic studies showed that XIAP was required for RhoGDIb mRNA stabilization by its RING positive regulating nucleolin mRNA stability via Erks-dependent manner. Consistently, XIAPregulated Erks/nucleolin/RhoGDIb axis was crucial for its promotion of BC cell invasion in vitro, while knockdown of RhoGDIb in T24T cells attenuated the lung metastasis of T24T cells in nude mice. Moreover, ectopic expression of GFP-RhoGDIb in XIAP-knocked down T24T cells, T24T(shXIAP/GFP-RhoGDIb), completely rescued their lung metastatic ability in nude mice. Our results clearly demonstrate that XIAP-mediated Erk activation upregulates nucleolin expression, which in turn bound to and stabilize RhoGDIb mRNA, and subsequently promotes human BC invasion in vitro and lung metastasis in vivo.
XIAP functions as an inhibitor of cell apoptosis primarily by inhibiting caspase activity. 34 Consequently, clinical studies demonstrate that XIAP is overexpressed in rental, prostate, breast and bladder cancer tissues coupled with studies depicting that XIAP inhibition sensitizes cancer cells to apoptosis, the nature of XIAP in cancer progression are also reported. 35, 36 Recent studies from our or other laboratories demonstrate that XIAP regulates cell migration and metastasis in colon cancer HCT116 cells via attenuating RhoGDIa SUMOylation. 7 Also, the complex of XIAP and survivin can activate the NF-jB transcription factor, in turn promoting cancer cell migration and metastasis in human prostate cancer cells. 8 Other studies report that XIAP can bind to and promotes Rac1 or C-RAF degradation via enhancing their poly-ubiquitination, while the attenuation of XIAP expression stabilizes Rac1 or C-RAF and in turn elevates cell migration. 10, 37 Those studies reveal that function of XIAP in regulation of cancer cell migration, invasion and metastasis is cell type-dependent manner. Our current studies found that XIAP was overexpressed in 66.7% of BC tissues in comparison to their paired adjacent normal bladder tissues. The results obtained from IHC staining showed that XIAP was also overexpressed in human BCs in comparison to the paired normal bladder tissues. The studies by using knockdown approach showed that XIAP expression was crucial for the invasion of human high-grade BC TccSup and T24T cells although it inhibited the migration of both cell lines. Our results demonstrate that XIAP plays differential roles in regulation of migration and invasion of human BC cells, providing additional evidence supporting that XIAP behavior in regulation of cancer cell migration and invasion is cancerand cell-type specific. RhoGDIb is a recently identified regulator of cancer cell motility and metastasis. 19, 38 The results from study in breast cancer show that RhoGDIb is involved in promoting cancer cell invasion, 39 and RhoGDIb overexpression has also been found in human cancer tissues from patients with colorectal and hepatocellular carcinoma in comparison to corresponding adjacent normal tissues. 40, 41 The clinical studies show that the RhoGDIb expression levels are associated with prognosis of colorectal cancer patients. 41 The patients with higher level of RhoGDIb expression have poor overall survival than those with low RhoGDIb expression relative to their adjacent normal gastric cancer and colorectal cancers. 18, 41 However, RhoGDIb expression is downregulated in lung cancer tissues, 42 and forced RhoGDIb expression reduces lung metastasis in mice. 43 RhoGDIb has been thought to be a suppressor for invasion and metastasis in human BCs. 13, 14 However, in current study, the overexpression of RhoGDIb is found in 11 of 12 bladder cancer tissues as compared to that in their paired adjacent normal tissues, and the results obtained from IHC staining also revealed the overexpression of RhoGDIb in human BCs in comparison to the paired normal bladders. These findings are distinct from previous reports. 13, 14 The explanation for the differential conclusions between the studies might be caused by methodology for evaluation and comparison. Since protein is the functional carrier, in current study we determined RhoGDIb protein expression in human BCs using a specific antibody against RhoGDIb with Western blot, in which only showed a specific antibody-recognized protein band at 27 kD, rather than determination of RhoGDIb mRNA levels or immunohistochemistry of BC Tissue Microarray. Moreover, we compared RhoGDIb protein expression in BCs in comparison to their adjacent normal tissues side by side, which resulted in more reliable results and conclusion. Our notion of RhoGDIb overexpression in BCs was also greatly supported by the clear data obtained from the studies of BBN-induced mouse high invasive BCs.
The function of RhoGDIb in regulating cancer cell motility is also dependent on cancer types and experimental systems. RhoGDIb induces the metastatic capacity of MDA-MB-231 breast cancer cells, 44 and suppressing expression of RhoGDIb significantly attenuates migration of ovarian or gastric cancer cells. 18, 38 Knockdown RhoGDIb expression increases the activation of matrix metallopeptidase 9 (MMP-9) and induces lung cancer cell A549 cell invasion. 45 Other reports demonstrate that RhoGDIb is a suppressor of bladder cancer cell metastasis, 13 and the phosphorylation of RhoGDIb plays a role with regards to regulating its function. 46 RhoGDIb phosphorylation at Tyr153 mediated by Src enhances its inhibitory effect on bladder cancer cell metastasis, 16 however, protein kinase C alpha (PKCa) induces RhoGDIb phosphorylation at Ser31 deactivates its GDI function via disrupting its interaction with Rac1, 46 whereas same group also reports that RhoGDIb overexpression increases Rac1 activity in human UMUC3 cells and such Rac1 activation is not associated with RhoGDIb regulation of BC cell migration and BC cell metastasis in UMUC3 cells. 19 It has also reported that repressing RhoGDIb expression enhances endothelin-1 signaling pathway which plays a critical role in promoting BC invasion and metastasis. 47 Our study here demonstrates that RhoGDIb was upregulated by XIAP in Erk/nucleolin-dependent manner with the diverse effects on regulation of BC cell migration and invasion. We found that XIAP-regulated RhoGDIb was able to promote human BC cell invasion, while it inhibited human BC cell migration in same BC cells. We also showed that XIAP was crucial factor for Erk activation and nucleolin protein expression, and that nucleolin subsequently stabilized RhoGDIb mRNA and elevated RhoGDIb protein expression. Collectively, XIAP-regulated RhoGDIb expression plays an important role in promoting human BC cell invasion and lung metastasis although it inhibits BC cell migration, in which potential mechanism underlying of RhoGDIb function might be distinct from RhoGDIb in regulating activation of Rac1 and MMP9 that has been reported in previous studies. 19, 48 This notion was supported by our most recent finding that migration and invasion in human BC cells are differential regulated by Superoxide dismutase (SOD) and matrix metalloproteinase-2 (MMP-2), respectively. 22 This novel discovery contributes to understanding of the molecular relationship between XIAP and RhoGDIb in mediating human BC invasion, and also provides value information for potential clinical therapy of patients with human-invasive BCs.
Although migration and invasion are complimentary stages in cancer metastasis, several studies demonstrate that some migration-related proteins had no effect on cell invasion. For example, Ets-1 promotes both migration and invasion of melanoma and Hela cells, whereas it regulates prostate PC3 cell migration, but not invasion. 49 In colon cancer cells, a-catenin is shown to be essential for cancer cell migration, but serves no role in cancer cell invasion. 50 Our results revealed the promoting effect of XIAP in BC cell invasion, while XIAP inhibited cell migration in same human BC cell lines T24T and TccSup. These results are consistent with our most recent findings that an inverse relationship between cell migration and invasion in human BC T24T and T24 cells. 22 We demonstrate that cell migration-related proteins CDC42 and Rac1 were suppressed in highly metastatic T24T cells, and their cell migration is inhibited in comparison to that of the less metastatic parental T24 cells. 22 Our further studies reveal that highly metastatic T24T cells have increased MMP-2 expression, which upregulates T24T invasion, whereas overexpression of SOD2 mediates the inhibition of cell migration of T24T cells. 22 Moreover, we have elucidated that nucleolin overexpression and translocation into the nucleus enhances mmp-2 mRNA stability, thus promoting T24T cell invasion; while Sp1 overexpression and activation plays an important role in SOD2 transcription and protein overexpression, as well as inhibition of cell migration inT24T cells. 22 Although our studies found that RhoGDIb served as XIAP downstream effector that is responsible for promotion of cancer cell invasion with inhibition of migration, the further identifying RhoGDIb downstream targets that mediate these diverse functions of RhoGDIb in regulation of human BC invasion and migration will warrant of high significances in understanding nature of RhoGDIb in modulation of BC cell motility and metastasis. Mammalian nucleolin protein consists of three domains: N-terminus, C-terminus and central domain, and there are four RNA binding domains locate in central domain, which can bind to AU-rich elements in 3 0 -UTR of target mRNA. 51 In our study, we found that RhoGDIb mRNA was stabilized by RNA binding protein nucleolin. Nucleolin directly bound to RhoGDIb mRNA was identified using RNA immunoprecipitation, which provides evidence that nucleolin might be involved in enhancing RhoGDIb mRNA stability. Further study indicated that XIAP expression was crucial for maintaining nucleolin mRNA stability in BC cells. Erk has been reported to be implicated in stabilizing nucleolin mRNA in cells exposed to phorbol 12-myristate 13-acetate. 33 The results obtained from our study indicated that attenuated XIAP expression led to suppression of Erk phosphorylation and nucleolin mRNA stability, whereas inhibition of Erk activation also impaired nucleolin mRNA stability, demonstrating that in BC cells, XIAP promotes Erk activation, which in turn stabilizes nucleolin mRNA and subsequently resulting in increases in RhoGDIb mRNA stability and expression. In conclusion, our study shows that XIAP is critical for promoting nucleolin expression, which in turn stabilizes RhoGDIb mRNA, subsequently regulating BC cell invasion and lung metastasis. The identification of the XIAP/ Erk/nucleolin/RhoGDIb pathway in BCs provides a significant insight into understanding of the diverse roles of XIAP beyond its conventional anti-apoptosis function. Our study leads to a significant change in current dogma regarding the importance of RhoGDIb in BC invasion and metastasis, which could lead to the development of new approaches that target RhoGDIb and/or XIAP for BC prevention and therapy.
